I don't think Gilead Sciences is a good stock for growth investors. Although the biotech company's earnings should jump this year, its revenue is likely to decline slightly. On the other hand ...

Shares of biopharmaceutical company Gilead Sciences (NASDAQ ... fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Shares of ROIV opened at $10.44 on Tuesday. Roivant Sciences has a 52-week low of $9.76 and a 52-week high of $13.06. The company has a market capitalization of $7.60 billion, a PE ratio of 1.85 ...

HOME DEPOT INC (HD) is a large-cap growth stock in the Retail (Home Improvement) industry. The rating using this strategy is 81% based on the firm’s underlying fundamentals and the stock’s ...

The stock price rose by 3.74% in premarket trading, reflecting positive investor sentiment. Anavex Life Sciences continues to focus on its lead drug candidate, blarcamesine, for Alzheimer's disease.

Sight Sciences stock opened at $2.92 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 9.74 and a current ratio of 10.18. The company has a market capitalization of $148. ...

Currently, Gilead Sciences has a market capitalization of $118.77 billion. Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $11,675.34 today ...

January hits new highs with $814 in dividend income, up 21% Y/Y. See how BDC investments drive growth toward $11,000 annual ...